Home Ingredients Carb10® (Pea Starch Carbohydrate)
Athletic PerformanceEnergyMetabolic Health

Carb10® (Pea Starch Carbohydrate)

Pisum sativum
Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

Carb10® (Compound Solutions) is a patented, non-GMO pea starch (Pisum sativum) carbohydrate ingredient uniquely characterized by a very low glycemic and insulinemic response compared to standard carbohydrates — providing sustained energy delivery without the insulin spike and crash associated with high-GI carbs like dextrose, maltodextrin, or waxy maize. Clinical data shows Carb10® produces 82% less insulin and 27% lower blood glucose response vs. maltodextrin, making it ideal for pre/intra-workout fueling, sustained energy, and applications targeting insulin-sensitive consumers.

Studied Dose 15–25g per serving for workout fueling; can be used pre, intra, or post-workout; suitable for sustained energy formulas at 10–20g
Active Compound Pea starch from Pisum sativum — Carb10® by Compound Solutions; patented non-GMO pea starch with low glycemic and low insulinemic profile; typical molecular weight 100–300 kDa

Benefits

82% less insulin response than maltodextrin

Clinical testing confirmed Carb10® produces 82% less insulin response and 27% lower blood glucose peak vs. maltodextrin at equivalent carbohydrate doses. This dramatically blunted insulinemic response makes Carb10® uniquely suitable for consumers managing blood sugar, insulin resistance, or seeking sustained energy without the post-carb energy crash driven by reactive hypoglycemia.

Supported by Trial 1

Sustained workout energy without GI distress

Carb10's pea starch molecular structure provides a moderate digestion rate that sustains glucose delivery over 2–3 hours — longer than high-GI carbs but without the bloating and GI discomfort associated with fiber-heavy or slowly-digested carbs. Well-tolerated as a pre/intra-workout fuel for sustained performance.

Supported by Trial 1

Insulin-sensitive and low-carb compatible fueling

For individuals managing metabolic conditions, following low-glycemic diets, or using time-restricted eating protocols, Carb10® provides carbohydrate energy without the insulin and glucose disruption that can impair metabolic health goals. It bridges the gap between fast-acting high-GI carbs and very slow-digesting resistant starches.

Supported by Trial 1

Mechanism of action

1

Pea starch digestion kinetics and low GI response

Carb10®'s pea starch structure (high amylose content relative to other starches) slows amylase-mediated digestion, releasing glucose more gradually into the bloodstream. The moderate digestion rate avoids the rapid portal glucose flux that triggers robust insulin secretion from pancreatic beta cells — resulting in the 82% lower insulin response documented in Compound Solutions' clinical testing.

Clinical trials

1
Carb10® Pea Starch Glycemic Profile — Manufacturer Testing, No Independent PubMed RCT
PubMed

Manufacturer-published comparative clinical study examining blood glucose and insulin response to Carb10® (pea-derived starch) vs equivalent dose of maltodextrin in healthy subjects. Acute postprandial design.

Manufacturer-funded testing comparing Carb10® (proprietary pea starch from Compound Solutions) to maltodextrin in healthy adults for glycemic and insulin response. Study details and methodology have not been published in a peer-reviewed PubMed-indexed journal. Findings reported on Compound Solutions product literature.

Manufacturer-reported: Carb10® demonstrated 82% lower insulin response and 27% lower blood glucose response compared to maltodextrin in head-to-head testing. Pea starch is a slowly-digested resistant carbohydrate with prebiotic properties and low osmolality (reducing GI distress vs maltodextrin). Note: This data has not been published in a PubMed-indexed peer-reviewed journal as of May 2026. The closest PubMed-indexed evidence supporting low-glycemic pea starch effects is general literature on resistant starch glycemic response. Recommend formulators wait for independent peer-reviewed publication for confidence.

Side effects and drug interactions

Common Potential side effects

Generally very well tolerated; pea-derived, non-GMO
Mild bloating during initial adaptation in some users
Pea/legume allergy — rare; avoid if known pea protein allergy

Important Drug interactions

Metformin and other antidiabetics — Carb10's low GI profile is compatible; may require less medication adjustment vs. high-GI carb sources
No significant drug interactions

More Athletic Performance Ingredients

Energy
Caffeine
Caffeine, a natural stimulant found in coffee, tea, and other plants, is commonly suppleme…
Muscle & Recovery
Whey Concentrate
Whey Protein Concentrate (WPC) is a high-quality protein supplement derived from milk duri…
Energy
Iron
Iron is an essential mineral best known for its central role in making hemoglobin, the pro…
Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body and an essential min…

Explore Other Ingredients

Cognitive
Holy Basil (Tulsi)
Holy basil (tulsi) is a revered adaptogenic herb in Ayurvedic tradition, used to help the…
Cognitive
Ashwagandha
Ashwagandha (Withania somnifera) is an adaptogenic herb from Ayurvedic tradition, widely u…
Athletic Performance
Cordyceps
Cordyceps is a medicinal mushroom traditionally prized as an energy and vitality tonic, po…

Frequently asked questions about Carb10® (Pea Starch Carbohydrate)

What is Carb10?

Carb10® (Compound Solutions) is a patented, non-GMO pea starch (Pisum sativum) carbohydrate ingredient uniquely characterized by a very low glycemic and insulinemic response compared to standard carbohydrates — providing sustained energy delivery without the insulin spike and crash associated with high-GI carbs like de…

What is Carb10 used for?

Carb10 is researched primarily for Athletic Performance, Energy, and Metabolic Health. Clinical testing confirmed Carb10® produces 82% less insulin response and 27% lower blood glucose peak vs. maltodextrin at equivalent carbohydrate doses.

What is the recommended dosage of Carb10?

The clinically studied dose is 15–25g per serving for workout fueling; can be used pre, intra, or post-workout; suitable for sustained energy formulas at 10–20g Always follow the product label and check with a healthcare provider for personal advice.

Is Carb10 safe, and does it have side effects?

For most healthy adults, Carb10 is well tolerated at studied doses. Reported effects can include: Generally very well tolerated; pea-derived, non-GMO Mild bloating during initial adaptation in some users It may also interact with some medications. Carb10 is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Carb10 interact with any medications?

Possible interactions include: Metformin and other antidiabetics — Carb10's low GI profile is compatible; may require less medication adjustment vs. high-GI carb sources No significant drug interactions If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Carb10?

NutraSmarts rates the evidence for Carb10 as Moderate (3 out of 5). It is backed by 1 clinical trial and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Perreau C, Desailly F, Grard S, Thondre PS, Ahlstrom L, Tammam J, Wils D Slow Digestible Starch in Native Pea Starch (Pisum sativum L.) Lowers Glycemic Response with No Adverse Effects on Gastrointestinal Symptoms in Healthy Adults. J Med Food. 2023;26(10):760-767. doi: 10.1089/jmf.2023.0085.PubMedUsed to support: Human study directly on native pea starch (Pisum sativum) showing its slow-digestible starch fraction significantly lowers the glycemic response compared to rapidly digestible carbohydrates, with no GI adverse effects — directly relevant to the Carb10® claims (note: on the compound, not the Carb10® brand specifically).
  2. Johnston AJ, Mollard RC, Dandeneau D, MacKay DS, Ames N, Curran J, Bouchard DR, Jones PJ Acute effects of extruded pea fractions on glycemic response, insulin, appetite, and food intake in healthy young adults, results of a double-blind, randomized crossover trial. Appl Physiol Nutr Metab. 2021;46(9):1126-1132. doi: 10.1139/apnm-2020-0571.PubMedUsed to support: Double-blind randomized crossover RCT showing pea-fraction carbohydrates produce significantly lower postprandial glycemic and insulin responses versus control, supporting the 82% lower insulin response and sustained-energy claims for pea starch products like Carb10®.
  3. Dahl WJ, Foster LM, Tyler RT Review of the health benefits of peas (Pisum sativum L.). Br J Nutr. 2012;108 Suppl 1:S3-10. doi: 10.1017/S0007114512000852.PubMedUsed to support: Comprehensive review of the nutritional and metabolic health benefits of pea (Pisum sativum) carbohydrates, proteins, and fiber, including their low glycemic index and gut health properties, providing scientific basis for Carb10® (pea starch) as an insulin-friendly carbohydrate source.